Kenvue Inc. (NYSE:KVUE) Shares Acquired by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 19.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,924,179 shares of the company's stock after buying an additional 3,025,924 shares during the quarter. Dimensional Fund Advisors LP owned 0.99% of Kenvue worth $404,002,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in KVUE. Grove Bank & Trust boosted its stake in shares of Kenvue by 438.4% during the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company's stock valued at $25,000 after acquiring an additional 947 shares during the last quarter. Geneos Wealth Management Inc. purchased a new position in Kenvue in the 4th quarter valued at about $29,000. SRS Capital Advisors Inc. boosted its stake in shares of Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after purchasing an additional 571 shares during the last quarter. Fortitude Family Office LLC grew its holdings in shares of Kenvue by 106.6% during the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company's stock worth $32,000 after buying an additional 777 shares in the last quarter. Finally, Versant Capital Management Inc raised its position in shares of Kenvue by 300.8% in the fourth quarter. Versant Capital Management Inc now owns 1,920 shares of the company's stock valued at $41,000 after buying an additional 1,441 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on KVUE shares. Evercore ISI initiated coverage on shares of Kenvue in a research report on Monday, March 24th. They set an "in-line" rating and a $25.00 target price on the stock. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Citigroup upped their target price on Kenvue from $21.00 to $22.00 and gave the company a "neutral" rating in a research note on Monday, April 14th. Redburn Atlantic initiated coverage on Kenvue in a research note on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price target on the stock. Finally, UBS Group dropped their price objective on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $24.42.

Kenvue Stock Down 0.3 %

Kenvue stock traded down $0.06 during trading on Friday, reaching $22.69. 4,071,787 shares of the company's stock were exchanged, compared to its average volume of 17,029,849. The company's 50-day moving average is $23.01 and its two-hundred day moving average is $22.42. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46. The firm has a market cap of $43.53 billion, a price-to-earnings ratio of 42.80, a PEG ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. On average, analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be paid a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.61%. Kenvue's dividend payout ratio (DPR) is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.